Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Spark's Gene Therapy Is On The Cusp Of Approval; Now It Gets Interesting

Oct 13 2017

• By Jessica Merrill

Eye

Related Content

ICER Eyes Gene Therapy: Category-wide Policy In Works As Spark Moves To Approval

Jul 05 2017

Spark's Vision Loss Gene Therapy Raises US FDA Questions About Novel Endpoint

Oct 11 2017

Spark's Gene Therapy Luxturna Sails Through US FDA Panel

Oct 13 2017

Cornering The Market On Innovation? The First CAR-T And The First Gene Therapy

Aug 31 2017

Gene Therapy Reimbursement: Is Blindness A Bad First Test?

Jun 29 2017

Related Companies

Spark Therapeutics, Inc.

Novartis AG

Express Scripts Holding Company

Additional Topics

Advisory Committees Market Access Drug Review Regulation Rare Diseases Regenerative Medicine Ophthalmic BioPharmaceutical

More from Drug Pricing

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window